Search research articles
Contact Us
Filters
Showing results (211-220 of 266) with videos related to
Page
of 27
Sort By:
Journal for Immunotherapy of Cancer
|
May 19, 2016
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
Mira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2015
Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
Christopher M Jackson, Christina M Kochel, Christopher J Nirschl, et al.
Journal for Immunotherapy of Cancer
|
June 27, 2017
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31<sup>st</sup>Annual Meeting of the Society for Immunotherapy of Cancer, 2016
Prasad S Adusumilli, Edward Cha, Mark Cornfeld, et al.
The Prostate
|
January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial
Danyelle A Winchester, Bora Gurel, Cathee Till, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 26, 2020
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial
Lauren M Hurwitz, Ibrahim Kulac, Berrak Gumuskaya, et al.
Journal for Immunotherapy of Cancer
|
November 9, 2016
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
Mira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2019
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Max Kates, Andres Matoso, Woonyoung Choi, et al.
The Prostate
|
June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
Danyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2023
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)
Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2020
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer
Aleksandar Z Obradovic, Matthew C Dallos, Marianna L Zahurak, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 266) with videos related to
Sort By:
Page
of 27
Journal for Immunotherapy of Cancer
|
May 19, 2016
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
Mira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2015
Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
Christopher M Jackson, Christina M Kochel, Christopher J Nirschl, et al.
Journal for Immunotherapy of Cancer
|
June 27, 2017
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31<sup>st</sup>Annual Meeting of the Society for Immunotherapy of Cancer, 2016
Prasad S Adusumilli, Edward Cha, Mark Cornfeld, et al.
The Prostate
|
January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial
Danyelle A Winchester, Bora Gurel, Cathee Till, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 26, 2020
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial
Lauren M Hurwitz, Ibrahim Kulac, Berrak Gumuskaya, et al.
Journal for Immunotherapy of Cancer
|
November 9, 2016
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
Mira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2019
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Max Kates, Andres Matoso, Woonyoung Choi, et al.
The Prostate
|
June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
Danyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2023
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)
Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2020
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer
Aleksandar Z Obradovic, Matthew C Dallos, Marianna L Zahurak, et al.
Page
of 27